Mapping the landscape of caregiver burden in Huntington's Disease: Current evidence and future directions

Katerina Poprelka1, Theodoros Fasilis1, Panayiotis Patrikelis1,2

  • 11st Department of Neurosurgery, National & Kapodistrian University of Athens, Athens, Greece.

PubMed

Insights

Informal caregivers of Huntington

Area of Science:

  • Neuroscience
  • Public Health
  • Caregiver Studies

Background:

  • Huntington's Disease (HD) is a rare neurodegenerative disorder.
  • HD significantly impacts patients and their informal caregivers.
  • Understanding caregiver burden is crucial for support.

Purpose of the Study:

  • To examine the burden experienced by informal caregivers of Huntington's Disease patients.
  • To identify factors influencing caregiver burden.

Main Methods:

  • Systematic review following PRISMA guidelines.
  • Searched PubMed, Science Direct, Taylor & Francis (Jan 2005 - Apr 2025).
  • Included 12 studies involving 569 caregivers; used CASP for quality appraisal.

Main Results:

  • Caregiver burden is linked to patient demographics, caregiver traits, disease factors, family dynamics, mental health, and support networks.
  • Neuropsychiatric symptoms and the hereditary nature of HD are key correlates of strain.
  • Studies conducted in Europe, North America, Australia, and South Korea.

Conclusions:

  • Caring for individuals with HD presents a complex, multifaceted burden.
  • Inadequate external support exacerbates caregiver strain.
  • Future research should focus on tailored interventions for HD caregivers across diverse contexts.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995